Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,396 total articles
SiriusPoint Ltd. announced the launch of a new Crisis Solutions business within its London Market Specialty division, targeting war, political violence, and terrorism risks. The company appointed Paul Beattie and Ed Winter as joint Heads of Crisis Solutions, bringing deep underwriting expertise and strong market relationships. The new platform will…
Palomar Holdings, Inc. has appointed Scott Beiser, former CEO and current Co-Chairman of investment bank Houlihan Lokey, to its Board of Directors. Beiser brings extensive leadership, corporate governance, and strategic planning expertise, expected to support Palomar's growth initiatives and shareholder value creation.
ONEOK, Inc., a leading midstream energy infrastructure company, announced its participation in an investor conference and a live webcast fireside chat scheduled for May 27, 2026. The company highlighted its extensive pipeline network and commitment to providing essential energy products and services domestically and internationally.
Firefly Aerospace has announced a proposed public offering of up to 4 million new shares along with 8 million shares from existing stockholders, subject to shareholder and market conditions. The proceeds from the sale of new shares will be used for general corporate purposes including supporting growth and recent program initiatives. The offering i…
FortuneX Acquisition Corp, a Cayman Islands-incorporated blank check company, completed its initial public offering of 7.5 million units priced at $10.00 per unit on May 22, 2026. The units each include one ordinary share and half a redeemable warrant, with warrants allowing purchase of ordinary shares at $11.50. The IPO raised $75 million with an …
Microchip Technology Incorporated announced its participation in the TD Cowen 54th Annual Technology, Media & Telecom Conference, where its CEO and CFO will present. The company is a broadline supplier of semiconductors serving multiple industries including industrial, automotive, aerospace, communications, and computing. The presentation will be w…
Shimmick Corporation successfully completed an underwritten public offering of approximately 4.29 million shares of common stock at $3.50 per share, raising about $14 million net. The company plans to use the proceeds for working capital and general corporate purposes, continuing its focus on water, energy, and critical infrastructure construction …
Spyre Therapeutics, a clinical-stage biotechnology firm specializing in long-acting antibodies for inflammatory bowel disease and rheumatic diseases, announced its participation in the upcoming Jefferies and Goldman Sachs Global Healthcare Conferences in June 2026, providing opportunities for investor engagement and presentations.
AGM Group Holdings Inc. received a notification from Nasdaq for delayed filing of its 2025 Form 20-F with the SEC. The company has 60 days to submit a compliance plan and potentially up to 180 additional days to regain compliance, while continuing efforts to complete the filing as soon as possible. There is no immediate impact on the stock's listin…
SPS Commerce, Inc., a leading intelligent supply chain network provider, announced that its management will present at the William Blair 46th Annual Growth Stock Conference on June 2, 2026. A webcast will be available to investors and interested parties.
Jade Biosciences has dosed the first participant in its first-in-human Phase 1 trial evaluating JADE201, an investigational half-life extended and afucosylated monoclonal antibody targeting BAFF-R to deplete B cells in autoimmune diseases. Interim data expected in 2027 will guide indication prioritization, particularly in rheumatoid arthritis, with…
Applied Materials, a leader in materials engineering for the semiconductor industry, announced a partnership with SCREEN Semiconductor Solutions at its new EPIC Center in Silicon Valley. This collaboration focuses on developing co-optimized wafer cleaning and materials engineering solutions to enable higher yields and faster commercialization of ne…
CarGurus, the leading automotive shopping platform in the U.S., announced that CEO Jason Trevisan will participate in a fireside chat at the upcoming BofA Securities 2026 Global Technology Conference. The event will highlight CarGurus' market leadership, innovative data-driven solutions for consumers and dealers, and its position in the automotive …
Seer, Inc. showcases its Proteograph Product Suite and AI-driven multi-cancer screening technology at the 2026 ASMS Annual Conference, highlighting breakthroughs in scalable proteomics and data processing infrastructure. Collaborations include large-scale plasma proteomics studies for precision medicine and advancements in biomarker discovery, unde…
Synchronoss Technologies partners with Globe Telecom to offer personal cloud solutions incorporating AI-powered features to over 54 million customers in the Philippines, aiming to enhance digital content management and security through accessible cloud storage tiers.
QCR Holdings, Inc. announced the re-election of four Class III directors to three-year terms at its annual stockholders meeting, and declared a cash dividend of $0.10 per share payable on July 3, 2026. The company, operating through its subsidiary banks in several Midwestern communities, reported $9.6 billion in assets as of March 31, 2026.
Myriad Genetics has launched Prolaris + AI, a novel prostate cancer diagnostic test that integrates molecular biomarker data with AI-driven digital pathology to better assess prostate cancer aggressiveness and personalize active surveillance plans. This innovative test enhances prognostic accuracy by combining traditional molecular scoring with an …
OrthoPediatrics Corp., a pediatric orthopedic-focused company, announced that its COO and CFO, Fred Hite, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference. The event will take place on June 8, 2026, in Miami Beach, with an audio webcast available to investors. The company markets nearly 90 pediatric …
Ming Shing Group Holdings Limited announced entering into a stock purchase agreement to acquire PMA Nano Carbon Tech Limited for $110 million through issuing convertible promissory notes. This acquisition aims to expand Ming Shing's portfolio into graphene-based thermal management technologies with applications across AI hardware cooling, new energ…
Structure Therapeutics announced participation in two major healthcare investor conferences in June 2026 to discuss its development of novel oral small molecule therapeutics targeting metabolic diseases such as obesity. Management will deliver presentations and conduct meetings, with webcasts accessible online.
Pool Corporation, the largest wholesale distributor of swimming pool and backyard products, announced its participation in several investor conferences throughout June 2026 to engage with the investment community and present its growth strategy.
Assembly Biosciences has completed a registered public offering of approximately 3.9 million common shares and 415,000 pre-funded warrants, raising gross proceeds of $115 million. The company plans to use the funds to advance clinical development of its therapeutic candidates targeting serious viral and liver diseases and for general corporate purp…
Zscaler Inc. announced its Q3 fiscal 2026 results with revenue and ARR growth of 25% YoY, record profitability with non-GAAP operating margin at 23%, and strong cash flow performance. The company highlighted strategic moves targeting AI-driven cybersecurity enhancements, including acquisitions and partnerships. Guidance for fiscal 2026 was raised, …
Kailera Therapeutics announced its first quarter 2026 financial results and clinical updates highlighting significant progress across four obesity-focused clinical-stage drug programs. The company initiated five late-stage global trials including the Phase 3 KaiNETIC program for ribupatide injection and reported positive topline data from partner H…
Apogee Therapeutics will report Part B 16-week data from the Phase 2 APEX trial of zumilokibart, a novel biologic targeting moderate-to-severe atopic dermatitis (AD), on May 27, 2026, followed by a webcast and conference call. The company aims to advance treatments in inflammatory and immunology markets with optimized antibody therapies, addressing…
